Pred Forte Related Published Studies
Well-designed clinical trials related to Pred Forte (Prednisolone Ophthalmic)
A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery. [2011.10]
Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. [2011.01]
Methylprednisolone applied directly to the round window reduces dizziness after cochlear implantation: a randomized clinical trial. [2011]
Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. [2010.10]
Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis. [2010.05]
Effect of oral prednisolone on visual outcomes and complications after scleral buckling. [2010.03]
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. [2009.01]
Efficacy of methylprednisolone injected into the masseter muscle following the surgical extraction of impacted lower third molars. [2008.03]
Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. [2008.02]
Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery. [2007.10]
High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. [2007.09]
Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. [2007.09]
Side effects of postoperative administration of methylprednisolone and gentamicin into the posterior sub-Tenon's space. [2007.05]
High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. [2007.01.31]
Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. [2007.01]
Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. [2006.02]
[Efficacy of prednisolone and rimexolone in HLA-B27 positive patients with acute anterior uveitis] [2005.09]
Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. [2005.08]
Well-designed clinical trials possibly related to Pred Forte (Prednisolone Ophthalmic)
Visual outcomes in treated bacterial keratitis: four years of prospective
follow-up. [2014]
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical
outcomes of a randomized controlled trial. [2014]
Anti-inflammatory therapy after selective laser trabeculoplasty: a randomized,
double-masked, placebo-controlled clinical trial. [2014]
The incidence of acute anterior uveitis after intravenous zoledronate. [2013]
Nocardia keratitis: clinical course and effect of corticosteroids. [2012]
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid
treatment. [2012]
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial
(SCUT). [2012]
Corticosteroids for Bacterial Keratitis: The Steroids for Corneal Ulcers Trial (SCUT). [2011.10.10]
Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid. [2011.09]
Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. [2011.05.25]
Influence of systemic steroids on subretinal fluid after scleral buckle surgery for macula-off retinal detachment. [2011.01]
Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in
the control of ocular cicatricial pemphigoid. [2011]
Levodopa-carbidopa may improve vision loss in indirect traumatic optic neuropathy. [2010.10]
Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. [2010.10]
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. [2010.05]
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. [2010.03]
The impact of anti-inflammatory therapy on intraocular pressure reduction following selective laser trabeculoplasty. [2010.01]
Plasma filtration in the treatment of Graves' ophthalmopathy: A randomized study. [2010]
Manipulation under local anesthesia in idiopathic frozen shoulder--a new effective and simple technique. [2009.12]
EMLA cream for carpal tunnel syndrome: how it compares with steroid injection. [2009.09]
A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. [2009.07]
Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK. [2009.02]
Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. [2008.11]
A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. [2008.10]
Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. [2008.07]
Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial. [2008.07]
The treatment of giant cell arteritis. [2008.06]
Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. [2008.03]
Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine. [2008.03]
Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. [2008.01]
[Basiliximab following penetrating risk-keratoplasty--a prospective randomized pilot study] [2008.01]
[Long-term results of FK 506 eye drops following corneal transplantation] [2008.01]
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]
Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. [2007.08]
Impact of short-term versus longterm topical steroid treatment on 'idiopathic' endothelial cell loss after normal-risk penetrating keratoplasty. [2007.03]
Effect of a topical antimicrobial paste on healing after extraction of molars in HIV positive patients: randomised controlled clinical trial. [2007.01]
Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. [2006.10]
Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. [2005.11]
Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. [2005.09]
Changes in bacterial and fungal ocular flora of clinically normal horses following experimental application of topical antimicrobial or antimicrobial-corticosteroid ophthalmic preparations. [2005.05]
[Ranking of systemic steroids after normal-risk keratoplasty. Results of a randomized prospective study] [2005.05]
Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study. [2005.02]
Other research related to Pred Forte (Prednisolone Ophthalmic)
Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of
inflammation after cataract surgery. [2013]
Effects of one-week versus one-day preoperative treatment with topical 1%
prednisolone acetate in dogs undergoing phacoemulsification. [2012]
Evaluation of Sustained Release of PLC-Loaded Prednisolone Acetate Microfilm on Postoperative Inflammation in an Experimental Model of Glaucoma Filtration Surgery. [2011.12]
Difluprednate for inflammatory eye disorders. [2011.05]
Reducing peak corneal haze after photorefractive keratectomy in rabbits: prednisolone acetate 1.00% versus cyclosporine A 0.05%. [2011.05]
Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK. [2011]
Difluprednate for inflammatory eye disorders. [2011]
Intraocular pressure elevation from topical difluprednate use. [2010.12]
A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes. [2010.10]
Durezol((R)) (Difluprednate Ophthalmic Emulsion 0.05%) Compared with Pred Forte((R)) 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis. [2010.09.01]
Effects of methyl prednisolone acetate, fibrin glue and combination of methyl prednisolone acetate and fibrin glue in prevention of epidural fibrosis in a rat model. [2010.09]
Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling inflammation after cataract surgery. [2010.07]
Development of new ophthalmic suspension prednisolone acetate 1%. [2010.04]
Optimization of prednisolone acetate-loaded chitosan microspheres using a 2(3) factorial design for preventing restenosis. [2010.04]
Comparison of Ketorolac Tromethamine and Prednisolone Acetate in Preventing Surgically Induced Miosis during Cataract Surgery. [2010.04]
Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling
inflammation after cataract surgery. [2010]
Comparison of orbital floor triamcinolone acetonide and oral prednisolone for
cataract surgery management in patients with non-infectious uveitis. [2010]
Effect of oral prednisolone on visual outcomes and complications after scleral
buckling. [2010]
Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation. [2009.12]
[Biodegradable systems containing prednisolone acetate for orbital administration] [2009.07]
Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy. [2009.05]
Comparative effects of different cosurfactants on sterile prednisolone acetate ocular submicron emulsions stability and release. [2009.03.01]
Case-control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection. [2009.03]
Inflammatory response after phacoemulsification treated with 0.5% prednisolone acetate or vehicle. [2008.11]
Methylprednisolone fails to preserve retinal ganglion cells and visual function after ocular ischemia in rats. [2008.11]
Effects of high-dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis. [2008.10]
Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. [2008.08]
Long term results of age-related macular degeneration therapy with prednisolone acetate--special refer to peripheral visual field changes. [2008.06]
Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis. [2008.06]
Treatment of ocular inflammatory conditions with loteprednol etabonate. [2008.04]
Does in vitro susceptibility predict clinical outcome in bacterial keratitis? [2008.03]
[Corneal allograft rejection: topical treatment vs. pulsed intravenous methylprednisolone - ten years' result] [2008.01]
Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. [2007.10]
Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. [2007.09]
Effects of intrathecal injection of prednisolone acetate on expression of NR2B subunit and nNOS in spinal cord of rats after chronic compression of dorsal root ganglia. [2007.09]
Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. [2007.08.31]
Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome. [2007.02]
Intravitreal prednisolone sodium succinate reduces diabetic macular edema without intraocular pressure rise. [2007.01]
Prednisolone neuroprotective therapy in age-related macular degeneration. [2007.01]
Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. [2006.04]
Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. [2005.09.14]
|